These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1981552)

  • 41. Modulation of atrial contraction by PKA and PKC during the compensated phase of eccentric cardiac hypertrophy.
    Haddad GE; Coleman BR; Zhao A; Blackwell KN
    Basic Res Cardiol; 2004 Sep; 99(5):317-27. PubMed ID: 15309409
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Function and role of the sarcoplasmic reticulum in heart disease].
    Reyes-Juárez JL; Zarain-Herzberg A
    Arch Cardiol Mex; 2006; 76 Suppl 4():S18-32. PubMed ID: 17469332
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mechanisms of reduced contractility in an animal model of hypertensive heart failure.
    Ward ML; Crossman DJ; Cannell MB
    Clin Exp Pharmacol Physiol; 2011 Oct; 38(10):711-6. PubMed ID: 21711381
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Regression of hypertrophy following nitrendipine: effect on systolic and diastolic function].
    Vogt M; Kreutz KU; Motz W; Strauer BE
    Z Kardiol; 1989 Jul; 78(7):469-77. PubMed ID: 2528245
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mechanical restitution of isolated human ventricular myocardium subjected to in vivo pressure and volume overload.
    Cooper IC; Fry CH; Webb-Peploe MM
    Cardiovasc Res; 1992 Oct; 26(10):978-82. PubMed ID: 1486592
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Changes in sympathetic neurotransmission and adrenergic control of cardiac contractility during 1,3-dipropyl-8-sulfophenylxanthine-induced hypertension.
    Rubino A; Burnstock G
    J Pharmacol Exp Ther; 1995 Oct; 275(1):422-8. PubMed ID: 7562580
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Elastic and contractile properties of the myocardium in experimental cardiac hypertrophy of the rat. Methodological and pathophysiological considerations.
    Jacob R; Brenner B; Ebrecht G; Holubarsch C; Medugorac I
    Basic Res Cardiol; 1980; 75(1):253-61. PubMed ID: 6446296
    [No Abstract]   [Full Text] [Related]  

  • 48. Biochemical, structural and mechanical defects of the failing myocardium.
    Newman WH
    Pharmacol Ther; 1983; 22(2):215-47. PubMed ID: 6140689
    [No Abstract]   [Full Text] [Related]  

  • 49. Aging, changes in the cardiovascular system, and responses to stress.
    Weisfeldt M
    Am J Hypertens; 1998 Mar; 11(3 Pt 2):41S-45S. PubMed ID: 9546036
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of myocardial relaxation in conditions of cardiac remodeling.
    Dukanović N; Jakovljević V; Mujović VM
    Med Pregl; 2009; 62(11-12):555-68. PubMed ID: 20491382
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Excitation-contraction coupling in heart failure.
    Lakatta EG
    Hosp Pract (Off Ed); 1991 Jul; 26(7):85-8, 91-8. PubMed ID: 1677009
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cellular adaptations of the myocardium to chronic exercise.
    Moore RL; Korzick DH
    Prog Cardiovasc Dis; 1995; 37(6):371-96. PubMed ID: 7777668
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modelling of hypertrophic heart potentiation with reference to morphological measurements.
    Nilius B; Scheufler K
    Exp Pathol (Jena); 1978; 15(2):74-84. PubMed ID: 150336
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diastolic function of the hypertrophied left ventricle in primary hypertension.
    Wikstrand J
    Clin Physiol; 1986 Apr; 6(2):115-27. PubMed ID: 2937604
    [No Abstract]   [Full Text] [Related]  

  • 55. Regulation of cardiac muscle function in the hypertensive heart.
    Lakatta EG
    Adv Exp Med Biol; 1991; 308():149-73. PubMed ID: 1801582
    [No Abstract]   [Full Text] [Related]  

  • 56. Myocardial adaptations in the failing heart: cause or consequence?
    van Dijk SJ; Hamdani N; Stienen GJ; van der Velden J
    J Muscle Res Cell Motil; 2008; 29(6-8):159-62. PubMed ID: 19219554
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Factors contributing to resistant hypertension. Cardiac considerations.
    Fouad-Tarazi FM
    Hypertension; 1988 Mar; 11(3 Pt 2):II84-7. PubMed ID: 2965108
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Progress in the risk assessment of hydroxychloroquine in frail elderly people.
    Castagna A; Ruotolo G; Manzo C
    Aging Med (Milton); 2021 Mar; 4(1):53-57. PubMed ID: 33738381
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The three integrated phases of left atrial macrophysiology and their interactions.
    Mehrzad R; Rajab M; Spodick DH
    Int J Mol Sci; 2014 Aug; 15(9):15146-60. PubMed ID: 25167138
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Low glial angiotensinogen improves body habitus, diastolic function, and exercise tolerance in aging male rats.
    Groban L; Wang H; Machado FS; Trask AJ; Kritchevsky SB; Ferrario CM; Diz DI
    Cardiovasc Endocrinol; 2012 Sep; 1(3):49-58. PubMed ID: 23795309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.